secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sanara MedTech Inc. (SMTI)
CIK:        0000714256
Form:       8-K
Filed at:   2026-10-16T13:20:58+00:00
Accession:  0001213900-26-110053
Event type: regulatory
Sentiment:  negative
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Sanara, MiMedx hit with FTC Second Request; HSR waiting period for merger extended
--------------------------------------------------------------------------------

- FTC issued a Second Request for additional information and documentary materials to Sanara MedTech and MiMedx on October 15, 2026, extending the HSR Act waiting period.
- Waiting period now runs 30 days after substantial compliance with the Second Request, unless extended voluntarily by the parties or terminated earlier by the FTC.
- Under the Merger Agreement, MiMedx's Mustang Merger Sub, Inc. merges into Sanara, with Sanara surviving as a wholly-owned subsidiary of MiMedx.
- Closing still conditioned on HSR waiting period expiration or termination plus other Merger Agreement conditions; Sanara says it continues to work constructively with the FTC.
- MiMedx filed a Form S-4 registration statement including Sanara's proxy/prospectus, which has been mailed to Sanara stockholders; 8-K signed by CFO Elizabeth Taylor on Oct 16, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/714256/000121390026110053/0001213900-26-110053-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/714256/000121390026110053/ea0308837-8k425_sanara.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-110053

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer